Endo Pharma ends collaboration on back pain drug Forbes Endo Pharmaceuticals Holdings Inc. said Wednesday that it is ending a partnership on an experimental back pain drug. Endo announced June 30 that the drug, axomadol, did not meet its main goal in a clinical trial that tested its ability to treat …
View post:
Endo Pharma ends collaboration on back pain drug – Forbes
